Inventor · disambiguated record
Gary D. Glick
Also filed as: GLICK GARY · GLICK GARY D
66 granted patents·49 pending applications·636 citations·filing 1997–2024
99Inventor score
Top patents by PatentIndex Score
115 records- 0199US10980756B1Methods of treatmentFIRST WAVE BIO INC·Filed 2020·Granted Apr 20, 2021·34 cites·26 claims
- 0297US10744103B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Aug 18, 2020·7 cites·29 claims
- 0397US7144880B2Compositions relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2003·Granted Dec 5, 2006·49 cites·10 claims
- 0496US11564896B2Methods of treatmentFIRST WAVE BIO INC·Filed 2021·Granted Jan 31, 2023·2 cites·16 claims
- 0596US10772854B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2018·Granted Sep 15, 2020·6 cites·72 claims
- 0696US7851465B2Compositions and methods relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2008·Granted Dec 14, 2010·32 cites·27 claims
- 0796US7683046B2Benzodiazepine compositions for treating epidermal hyperplasia and related disordersUNIV MICHIGAN·Filed 2008·Granted Mar 23, 2010·31 cites·12 claims
- 0896US7276348B2Compositions and methods relating to F1F0-ATPase inhibitors and targets thereofUNIV MICHIGAN·Filed 2004·Granted Oct 2, 2007·54 cites·8 claims
- 0995US10912746B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 9, 2021·3 cites·20 claims
- 1095US10905666B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 2, 2021·3 cites·26 claims
- 1195US10849867B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Dec 1, 2020·3 cites·28 claims
- 1295US10799468B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Oct 13, 2020·3 cites·28 claims
- 1395US7638624B2Compositions and methods relating to novel benzodiazepine compounds and derivativesUNIV MICHIGAN·Filed 2006·Granted Dec 29, 2009·35 cites·19 claims
- 1495US7125866B1Therapeutic applications of pro-apoptotic benzodiazepinesUNIV MICHIGAN·Filed 2000·Granted Oct 24, 2006·63 cites·4 claims
- 1594US10292951B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2016·Granted May 21, 2019·9 cites·60 claims
- 1693US10604542B2Cyclic dinucleotides for treating conditions associated with sting activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 1793US10556903B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Feb 11, 2020·12 cites·5 claims
- 1892US10533005B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted Jan 14, 2020·9 cites·41 claims
- 1991US7572788B2Compositions and methods relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2003·Granted Aug 11, 2009·35 cites·19 claims
- 2091US7220739B2Therapeutic application of pro-apoptotic benzodiazepinesUNIV MICHIGAN·Filed 2001·Granted May 22, 2007·35 cites·3 claims
- 2190US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 2290US9512111B2N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseGLICK GARY D·Filed 2011·Granted Dec 6, 2016·21 cites·15 claims
- 2389US10961270B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Mar 30, 2021·2 cites·7 claims
- 2488US9370507B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Jun 21, 2016·8 cites·27 claims
- 2588US9000014B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Apr 7, 2015·12 cites·26 claims
- 2688US8497307B2Aryl guanidine F1F0-ATPase inhibitors and related methodsGLICK GARY D·Filed 2009·Granted Jul 30, 2013·20 cites·26 claims
- 2788US8324258B2F1F0-ATPase inhibitors and related methodsGLICK GARY D·Filed 2008·Granted Dec 4, 2012·20 cites·15 claims
- 2888US6080588ATherapeutic methods for benzodiazepine derivativesUNIV MICHIGAN·Filed 1997·Granted Jun 27, 2000·81 cites·3 claims
- 2987US10533007B2NLRP3 modulatorsInnate Tumor Immunity·Filed 2017·Granted Jan 14, 2020·10 cites·2 claims
- 3087US9139532B2Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Sep 22, 2015·8 cites·32 claims
- 3187US2024074995A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2023·Application pending·0 cites
- 3285US12351580B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2023·Granted Jul 8, 2025·0 cites·6 claims
- 3385US9580388B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Feb 28, 2017·4 cites·27 claims
- 3485US8722667B2Compositions and methods for inhibiting the proliferation of cellsUNIV MICHIGAN·Filed 2012·Granted May 13, 2014·2 cites·12 claims
- 3584US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 3684US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 3784US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 3881US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 3980US2023201143A1Methods of treatmentFIRST WAVE BIO INC·Filed 2022·Application pending·0 cites
- 4079US8242109B2Compositions and methods relating to novel compounds and targets thereofGLICK GARY D·Filed 2010·Granted Aug 14, 2012·3 cites·15 claims
- 4178US11793777B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2021·Granted Oct 24, 2023·0 cites·18 claims
- 4278US11072612B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 27, 2021·1 cites·5 claims
- 4377US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4477US2022000812A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2021·Application pending·0 cites
- 4576US11744812B2Methods of treatmentFIRST WAVE BIO INC·Filed 2021·Granted Sep 5, 2023·0 cites·27 claims
- 4676US8604023B21,4-benzodiazepinone compounds and their use in treating cancerGLICK GARY D·Filed 2010·Granted Dec 10, 2013·2 cites·24 claims
- 4775US9932313B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2017·Granted Apr 3, 2018·1 cites·25 claims
- 4875US8088759B21,4-benzodiazepine-2,5-diones with therapeutic propertiesGLICK GARY D·Filed 2006·Granted Jan 3, 2012·1 cites·14 claims
- 4975US2020276140A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Application pending·0 cites
- 5074US11760735B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2022·Granted Sep 19, 2023·0 cites·9 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →